REFERENCES
  1. Mulliez SM, De Keyser F, Verbist C, Vantilborgh A, Wijns W, Beukinga I et al. Lupus anticoagulant-hypoprothrombinemia syndrome: report of two cases and review of the literature. Lupus . 2015; 24:736–45.
  2. Bajaj SP, Rapaport SI, Fierer DS, Herbst KD, Schwartz DB. A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome. Blood. 1983; 61:684–692
  3. Fleck RA, Rapaport SI, Rao LV. Anti-prothrombin antibodies and the lupus anticoagulant. Blood . 1988; 72: 512-9
  4. Sarker T, Roy S, Hollon W, Rajpurkar M. Lupus anticoagulant acquired hypoprothrombinemia syndrome in childhood: two distinct patterns and review of the literature. Haemophilia . 2015; 21:754–60.
  5. Mazodier K, Arnaud L, Mathian A, Costedoat-Chalumeau N, Haroche J, Frances C et al. Lupus anticoagulant-hypoprothrombinemia syndrome: report of 8 cases and review of the literature. Medicine (Baltimore). 2012; 91: 251-260.
  6. Taddio A, Brescia A, Lepore L, D´Rose C. Steady improvement of prothrombin levels after cyclophosphamide therapy in pediatric lupus anticoagulant syndrome (LAHPS). Clinical rheumatology . 2007; 26: 2167-2169.
  7. Simel DL, St Clair EW, Adams J, Greenberg CS. Correction of hypoprothrombinemia by immunosuppressive treatment of the lupus-anticoagulant hypoprothrombinemia syndrome. American Journal of Medicine . 1987; 83: 563-6.
  8. Eberhard A, Sparling C, Sudbury S, Ford P, Laxer R. Hypoprothrombinemia in childhood systemic lupus erythematosus.Seminars in Arthritis and Rheumatism . 1994; 24: 12-18
  9. Erkan D, Bateman H, Lockshin MD. Lupus anticoagulanthypoprothrombinemia syndrome associated with systemic lupus erythematosus: report of two cases and review of the literature.Lupus 1999; 8:560-4
  10. Pernod G, Arvieux J, Carpentier PH, Mossuz P, Bosson JL, Polack B. Succesful treatment of lupus-anticoagulant hypoprothrombinea syndrome using intravenous immunoglobulins. Thrombosis Haemostasis . 1997; 78: 969-70
  11. Ford A, Baca N, Buchbinder D, Mahajerin A. Lupus anticoagulant hypoprothrombinemia syndrome associated with severe thrombocytopenia in a child. Pediatric Blood & Cancer . 2016; 64: 1-4.
  12. Cetin Gedik K, Siddique S, Aguiar CL. Rituximab use in pediatric lupus anticoagulant hypoprothrombinemia syndrome – report of three cases and review of the literature. Lupus . 2018; 27: 1190- 1197.
  13. Paschal RD, Neff AT. Resolution of hypoprothrombinemia-lupus anticoagulant syndrome (HLAS) after multidrug therapy with rituximab: a case report and review of the literature. Haemophilia . 2013; 19: 62-65.